Sorted By:

Relevance


Health Care Access Concerns in the Media Spotlight

Access Better Coverage  |  From Our Network

The consulting firm found that silver plans charging coinsurance greater than 30 percent for specialty meds have risen from 27 percent in 2014 to 41 percent in 2015.
http://www.accessbettercoverage.org/articles/health-care-access-concerns-in-the-media-spotlight

PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President

PhRMA  |  Press Release

Moscicki previously also served on staff at Massachusetts General Hospital and on the faculty of Harvard Medical School.
https://www.phrma.org

India denies patent on novel HIV/AIDS medicine

PhRMA  |  Blog Post

Nearly two years into Prime Minister Modi’s Administration, there still remains a high degree of uncertainty for innovators who want to do business in India.
http://catalyst.phrma.org/india-denies-patent-on-novel-hiv-aids-medicine

PhRMA Comment: Medical Product Communications That Are Consistent With the FDA-Required Labeling—Questions and Answers

PhRMA  |  Speeches & Communication

PhRMA's comments on the FDA's draft guidance entitled “Medical Product Communications That Are Consistent With the FDA-Required Labeling—Questions and Answers” (“Draft Guidance”).
https://www.phrma.org

Value

PhRMA  |  From PhRMA

New medicines discovered and developed by America’s biopharmaceutical research companies are helping people lead longer, more productive lives, controlling healthcare costs and stimulating the economy through high-quality jobs and a healthier workforce.
https://www.phrma.org/media/value

PhRMA Comment: Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products

PhRMA  |  Speeches & Communication

PhRMA's comments in response to FDA’s notification of public hearing about manufacturer communications regarding unapproved uses of approved or cleared medical products (“FDA hearing notice”) and FDA’s Memorandum titled “Public Health Interests and First Amendment Considerations Related to Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products” (the “First Amendment Memorandum”).
https://www.phrma.org

PhRMA Statement on Medical Innovation

PhRMA  |  Press Release

It is a challenge, but the Cleveland Clinical Top 10 Medical Innovations list demonstrates the remarkable advances that can be achieved.”
https://www.phrma.org/press-release/phrma-statement-on-medical-innovation

Part B Medicines Represent Significant Medical Advances

Chartpack  |  From Our Network

Part B medicines have yielded breakthroughs in cancer, arthritis and autoimmune diseases like lupus....
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/part-b-medicines-represent-significant-medical-advances

Ads: Let's Talk About Cost

PhRMA  |  From PhRMA

Discussions about costs are important. No patient should have to worry about whether they can afford the care they need. At the same time, it is important to look at costs across the health care system and not just the share going toward life changing medicines. Explore our ads below to l...
https://www.phrma.org/media/ads-let-s-talk-about-cost

Cost & Value of Medicines

PhRMA  |  From PhRMA

.23rem; line-height: 1.6; text-rendering: optimizeLegibility; color: #818185; font-family: proxima-nova, sans-serif; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; lett...
https://www.phrma.org/media/prescription-medicines-costs-in-context-graphics-and-videos

Rotary International and Global Partners Contribute to a Polio-Free India

PhRMA  |  Press Release

The achievement of the India program, led by the Government of India and partners – Rotary International, WHO, UNICEF, and the US Centers for Disease Control and Prevention –to ensure that each and every child is reached by the vaccine in the upcoming immunization rounds will rid the country of polio."
https://www.phrma.org/press-release/rotary-international-and-global-partners-contribute-to-a-polio-free-india

Medical Mysteries of the Heart

From Hope To Cures  |  From Our Network

From 2003 to 2013, the death rate from coronary heart disease plunged by about 38 percent, thanks to better control of cholesterol and blood pressure, a decline in smoking rates, improved medical treatments and faster care of people after a heart attack.
http://www.fromhopetocures.org/medical-mysteries-of-the-heart

Industry Economic Impact

PhRMA  |  From PhRMA

The biopharmaceutical sector in the United States spurs economic activity and generates jobs across a whole range of sectors, from vendors and suppliers to the economic activity of its workforce. These benefits are felt far beyond individual biopharmaceutical companies and are built upon a robust...
https://www.phrma.org/media/industry-economic-impact

Patients Facing Access Restrictions Incur Greater Medical Spending

Chartpack  |  From Our Network

Non-elderly Medicaid patients facing formulary restrictions for antipsychotic medications were 7% to 13% more likely to be hospitalized and had higher medical costs than patients in states without formulary restrictions.
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicaid/patients-facing-access-restrictions-incur-greater-medical-spending

Disaster Relief

PhRMA  |  From PhRMA

When disaster strikes, medical care and medicines are urgently needed; yet disaster events can also impact patient access to the medicines they need.
https://www.phrma.org/media/disaster-relief

Prime Minister Modi’s U.S. Visit a Prime Opportunity to Strengthen U.S.-India Ties

PhRMA  |  Blog Post

Upon his election, Prime Minister Modi declared that India was “open for business”, and he has seemed genuine about living up to his campaign promises and attracting the kinds of investment that will chart a new, positive course for India’s economy.
http://catalyst.phrma.org/prime-minister-modis-u.s.-visit-a-prime-opportunity-to-strengthen-u.s.-india-ties

5 Tips For Handling Early-Year Medical Expenses

From Hope To Cures  |  From Our Network

These accounts can let families set aside as much as $6,650 before taxes for medical expenses, and employers often contribute to them.
http://www.fromhopetocures.org/5-tips-for-handling-early-year-medical-expenses

The U.S.– India Relationship is Full of Opportunities

PhRMA  |  Blog Post

-India relationship.
http://catalyst.phrma.org/the-us-india-relationship-is-full-of-opportunities

Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey

PhRMA  |  Blog Post

In a world of global investment flows, securing a larger portion of the $150 billion invested per year by the research-based biopharmaceutical industry is anyone’s game. The 2017 results of the annual .pugatch-consilium.com/re...
http://catalyst.phrma.org/policy-conditions-make-or-break-leaders-in-biopharmaceutical-innovation-preliminary-results-from-the-2017-bci-survey

Medicare Monday: How MedPAC recommendations would actually increase beneficiary costs

PhRMA  |  Blog Post

Perhaps it’s time for MedPAC to take into consideration broad stakeholder concerns with such proposals. 
http://catalyst.phrma.org/medicare-monday-how-medpac-recommendations-would-actually-increase-beneficiary-costs

I Am Research. Progress. Hope.

PhRMA  |  From PhRMA

Science defines the biopharmaceutical industry; it provides the necessary foundation for researchers to conduct complex innovative work in the search for new medicines and cures for patients suffering from disease.  While the biopharmaceutical research sector is one of the most science-dr...
https://www.phrma.org/media/i-am-research-progress-hope

STEM

PhRMA  |  From PhRMA

In an increasingly competitive global environment, it is critical that the U.S. strengthen its standing in science, technology, engineering and math (STEM) education to stay ahead of other countries, like China and Singapore, in order to continue create more high-wage research and developme...
https://www.phrma.org/media/stem-growing-our-next-generation-of-innovators

Prescription Medicines Are Part of the Solution to Reducing Medical Spending

Chartpack  |  From Our Network

Better use of medicines reduces use of avoidable medical care, resulting in reductions in medical spending.
http://chartpack.phrma.org/biophrma-chartpack/outcomes-and-savings/prescription-medicines-are-part-of-the-solution-to-reducing-medical-spending

PhRMA Statement on Flawed British Medical Journal Analysis

PhRMA  |  Press Release

“Ultimately, to help ensure that the U.S. remains the world leader in medical innovation, a consistent pro-innovation policy framework must be in place that provides regulatory certainty, ensures patient choice and access to medicines and incentivizes future research and development.”
https://www.phrma.org/press-release/phrma-statement-on-flawed-british-medical-journal-analysis

You have reviewed the first 50 results out of 1046. Each page contains 25 results. You're on page 2.

prev 1 2 3 4 5 6 next